To make corrections with respect to Food and Drug Administration user fees.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs.
Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Committee on Energy and Commerce discharged.
Committee on Energy and Commerce discharged.
Mr. Upton asked unanimous consent to discharge from committee and consider.
Considered by unanimous consent. (consideration: CR H6137-6138)
Passed/agreed to in House: On passage Passed without objection.(text: CR H6137-6138)
On passage Passed without objection. (text: CR H6137-6138)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate, read twice.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR 9/21/2012 S6671)
Passed Senate without amendment by Unanimous Consent. (consideration: CR 9/21/2012 S6671)
Message on Senate action sent to the House.
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 112-193.
Became Public Law No: 112-193.
Enacted as Public Law 112-193
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line